Systemic delivery of nintedanib using PLGA-based discoidal polymeric particles for idiopathic pulmonary fibrosis treatment

Somogyi, 2019, The therapy of idiopathic pulmonary fibrosis: what is next?, Eur. Respir. Rev., 28, 10.1183/16000617.0021-2019 Bae, 2022, Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study, Thorax, 77, 470, 10.1136/thoraxjnl-2020-215386 Walters, 2020, Occupational exposures and idiopathic pulmonary fibrosis, Curr. Opin. Allergy Clin. Immunol., 20, 103, 10.1097/ACI.0000000000000610 Caverly, 2019, Past, present, and future research on the lung microbiome in inflammatory airway disease, Chest, 156, 376, 10.1016/j.chest.2019.05.011 Ryerson, 2018, The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?, Eur. Respiratory Soc., 51 Aquino-Galvez, 2019, Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis, Respir. Res., 20, 130, 10.1186/s12931-019-1100-4 Fraser, 2016, Therapeutic advances in idiopathic pulmonary fibrosis, Clin. Med., 16, 42, 10.7861/clinmedicine.16-1-42 Laporta Hernandez, 2018, Lung transplantation in idiopathic pulmonary fibrosis, Med. Sci., 6, 68 Hilberg, 2018, Triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases, J. Pharmacol. Exp. Therapeut., 364, 494, 10.1124/jpet.117.244129 Jamadar, 2021, The tyrosine-kinase inhibitor nintedanib ameliorates autosomal-dominant polycystic kidney disease, Cell Death Dis., 12, 947, 10.1038/s41419-021-04248-9 Gad, 2020, The anti-fibrotic and anti-inflammatory potential of bone marrow-derived mesenchymal stem cells and nintedanib in bleomycin-induced lung fibrosis in rats, Inflammation, 43, 123, 10.1007/s10753-019-01101-2 Wollin, 2015, Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis, Eur. Respir. J., 45, 1434, 10.1183/09031936.00174914 Richeldi, 2020, Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis, BMC Pulm. Med., 20, 3, 10.1186/s12890-019-1030-4 Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N. Engl. J. Med., 370, 2071, 10.1056/NEJMoa1402584 Xu, 2019, Subgroup analysis for Chinese patients included in the INPULSIS® trials on nintedanib in idiopathic pulmonary fibrosis, Adv. Ther., 36, 621, 10.1007/s12325-019-0887-1 Wang, 2018, Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: a review, Int. J. Pharm., 535, 253, 10.1016/j.ijpharm.2017.11.003 Almeida, 2011, In vivo biodistribution of nanoparticles, Nanomedicine, 6, 815, 10.2217/nnm.11.79 Sabourian, 2020, Effect of physico-chemical properties of nanoparticles on their intracellular uptake, Int. J. Mol. Sci., 21, 8019, 10.3390/ijms21218019 Qiu, 2019, Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis, Theranostics, 9, 2618, 10.7150/thno.32363 Li, 2021, Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes, Nano Today, 37, 10.1016/j.nantod.2020.101061 Tavares, 2017, Effect of removing Kupffer cells on nanoparticle tumor delivery, Proc. Natl. Acad. Sci. U. S. A., 114, E10871, 10.1073/pnas.1713390114 Decuzzi, 2010, Size and shape effects in the biodistribution of intravascularly injected particles, J. Control Release, 141, 320, 10.1016/j.jconrel.2009.10.014 Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 Park, 2019, Biodegradable micro-sized discoidal polymeric particles for lung-targeted delivery system, Biomaterials, 218, 10.1016/j.biomaterials.2019.119331 Park, 2021, Potential roles of the glass transition temperature of PLGA microparticles in drug release kinetics, Mol. Pharm., 18, 18, 10.1021/acs.molpharmaceut.0c01089 Emami, 2019, Poly (lactic acid)/poly (lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery, J. Pharm. Investig., 49, 427, 10.1007/s40005-019-00443-1 Alkholief, 2022, Effect of solvents, stabilizers and the concentration of stabilizers on the physical properties of poly(d,l-lactide-co-glycolide) nanoparticles: encapsulation, in vitro release of indomethacin and cytotoxicity against HepG2-cell, Pharmaceutics, 14, 870, 10.3390/pharmaceutics14040870 Blasi, 2019, Poly (lactic acid)/poly (lactic-co-glycolic acid)-based microparticles: an overview, J. Pharm. Investig., 49, 337, 10.1007/s40005-019-00453-z Nguyen, 2019, Biomimetic surface modification of discoidal polymeric particles, Nanomedicine, 16, 79, 10.1016/j.nano.2018.11.011 Key, 2013, Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging, Biomaterials, 34, 5402, 10.1016/j.biomaterials.2013.03.078 Key, 2015, Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors, ACS Nano, 9, 11628, 10.1021/acsnano.5b04866 Park, 2020, Therapeutic efficacy of curcumin enhanced by microscale discoidal polymeric particles in a murine asthma model, Pharmaceutics, 12, 739, 10.3390/pharmaceutics12080739 Sun, 2017, Murine bronchoalveolar lavage, Bio. Protoc., 7, e2287, 10.21769/BioProtoc.2287 Mecozzi, 2020, In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach, Sci. Rep., 10, 10.1038/s41598-020-71293-3 Blandinières, 2018, Endothelial colony-forming cells do not participate to fibrogenesis in a bleomycin-induced pulmonary fibrosis model in nude mice, Stem Cell Rev. Rep., 14, 812, 10.1007/s12015-018-9846-5 Birk, 2020, Automatization and improvement of μCT analysis for murine lung disease models using a deep learning approach, Respir. Res., 21, 124, 10.1186/s12931-020-01370-8 Ali, 2018, A review on nanofluids: fabrication, stability, and thermophysical properties, J. Nanomater., 2018, 33, 10.1155/2018/6978130 Sikora, 2015, A systematic comparison of different techniques to determine the zeta potential of silica nanoparticles in biological medium, Anal. Methods, 7, 9835, 10.1039/C5AY02014J Joseph, 2019, Multifunctional nanocrystals for cancer therapy: a potential nanocarrier, Nanomater. Drug Delivery Therap, 91, 10.1016/B978-0-12-816505-8.00007-2 Kamble, 2022, Revisiting zeta potential, the key feature of interfacial phenomena, with applications and recent advancements, ChemistrySelect, 7, 10.1002/slct.202103084 Danaei, 2018, Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems, Pharmaceutics, 10, 57, 10.3390/pharmaceutics10020057 Masarudin, 2015, Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin, Nanotechnol. Sci. Appl., 8, 67, 10.2147/NSA.S91785 Wind, 2019, Clinical pharmacokinetics and pharmacodynamics of nintedanib, Clin. Pharmacokinet., 58, 1131, 10.1007/s40262-019-00766-0 Ackermann, 2020, Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases, Eur. Respir. J., 55, 10.1183/13993003.00933-2019 Wang, 2021, Dynamic observation of autophagy and transcriptome profiles in a mouse model of bleomycin-induced pulmonary fibrosis, Front. Mol. Biosci., 8 Della Latta, 2015, Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions, Pharmacol. Res., 97, 122, 10.1016/j.phrs.2015.04.012 Brun, 2021, Metabolic influences modulating erythrocyte deformability and eryptosis, Metabolites, 12, 4, 10.3390/metabo12010004 Toren, 2021, Systems biology analysis of lung fibrosis-related genes in the bleomycin mouse model, Sci. Rep., 11, 19269, 10.1038/s41598-021-98674-6 Zhu, 2022, Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways, Eur. J. Pharm. Sci., 168, 10.1016/j.ejps.2021.106047 Valor, 2021, Determining the optimal conditions for the production by supercritical CO2 of biodegradable PLGA foams for the controlled release of Rutin as a medical treatment, Polymers, 13, 1645, 10.3390/polym13101645 Roces, 2020, Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics, Drug Deliv. Transl. Res., 10, 582, 10.1007/s13346-019-00699-y